Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Vor Biopharma Inc
VORCurrent price
0.96 USD
-0.041 USD (-4.12%)
Last closed
0.99 USD
Company
www.vorbio.com
ISIN
US9290331084
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
65 526 052 USD
Yield for 12 month
-50.06 %
1Y
3Y
5Y
10Y
15Y
VOR
Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. Its lead product is tremtelectogene empogeditemcel (trem-cel), an engineered hematopoietic stem cell (eHSC) product candidate that is in phase 1/2 trial to treat acute myeloid leukemia (AML) and other hematological malignancies. The company is also developing Mylotarg, a CD33-directed antibody drug conjugate (ADC) therapy for patients with leukemia; VCAR33, a CAR-T therapy designed to target CD33, a clinically validated target for AML, which are under preclinical and Phase 1/2 clinical studies; trem-cel + VCAR33 treatment system that is under preclinical studies for the treatment of AML; and CD33-CLL1 treatment system made with CD33-CLL1 multiplex-engineered eHSC and CD33-CLL1 multi-specific CAR-T, which are under preclinical studies for the treatment of AML. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: 100 Cambridgepark Drive, Cambridge, MA, United States, 02140
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
11.94 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-3 492 000 USD
Last Year
-8 960 000 USD
Current Quarter
-900 000 USD
Last Quarter
-943 000 USD
Key Figures VOR
1 year
3 years
5 years
10 years
EBITDA
-121 204 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-39.74 %
PEG Ratio
–
Return On Equity TTM
-78.07 %
Wall Street Target Price
11.94 USD
Revenue TTM
–
Book Value
2.22 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.73 USD
Diluted Eps TTM
-1.73 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics VOR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VOR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation VOR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-3.0931
Price Book MRQ
0.6681
Financials VOR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VOR
For 52 weeks
0.63 USD
3.14 USD
50 Day MA
0.8 USD
Shares Short Prior Month
1 972 048
200 Day MA
1.38 USD
Short Ratio
2.99
Shares Short
1 705 788
Short Percent
4.58 %
BeatStart